Work

Efficacy and safety of durvalumab with or without tremelimumab in metastatic NSCLC: A meta-analysis of randomized controlled trials.

Year: 2026

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e20568

Authors: Ursula Medeiros Araujo de Matos, Henrique Guimarães Barbosa Coelho, Moana Divina da Silva Santiago, Fatih Burak Kaner, Nathaniel D. Robinson

Institutions: University of Connecticut, UConn Health, University of Colorado Anschutz

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162684747

FWCI:

Cites:

Cited by:

Related to: